C

Canntab Therapeutics Ltd
OTC:CTABF

Watchlist Manager
Canntab Therapeutics Ltd
OTC:CTABF
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 3.9k USD

Intrinsic Value

CTABF doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of CTABF.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTABF Intrinsic Value
Not Available
C
Base Case Scenario
Compare CTABF to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PILL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Canntab Therapeutics Ltd

Current Assets 336k
Cash & Short-Term Investments 16.8k
Receivables 32k
Other Current Assets 287.2k
Non-Current Assets 617.5k
PP&E 341.7k
Intangibles 275.8k
Current Liabilities 3.1m
Accounts Payable 203.6k
Accrued Liabilities 847k
Short-Term Debt 60k
Other Current Liabilities 2m
Efficiency

Free Cash Flow Analysis
Canntab Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Canntab Therapeutics Ltd

Revenue
73.5k CAD
Cost of Revenue
-105.8k CAD
Gross Profit
-32.3k CAD
Operating Expenses
-2.1m CAD
Operating Income
-2.2m CAD
Other Expenses
-1.2m CAD
Net Income
-3.4m CAD
Fundamental Scores

CTABF Profitability Score
Profitability Due Diligence

Canntab Therapeutics Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROIC is Increasing
Sustainable 3Y Average Gross Margin
Declining Gross Margin
22/100
Profitability
Score

Canntab Therapeutics Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

CTABF Solvency Score
Solvency Due Diligence

Canntab Therapeutics Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
32/100
Solvency
Score

Canntab Therapeutics Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTABF Price Targets Summary
Canntab Therapeutics Ltd

There are no price targets for CTABF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PILL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y